Synthetic and natural alternatives to traditional antibodies offer more control, specificity, and reproducibility. 

This guide for apps comes from personal experience testing various programs aimed to improve productivity or to help with selecting reagents.

Genetic analyses uncover cellular hallmarks of bladder cancer tumors that don’t respond, but interfering with one of those characteristics in a mouse model causes tumors to shrink.  

With multiple applications in biomedicine, the antibodies can now be made quickly, cheaply, and without the need for an alpaca or one of its relatives.

Mice receiving the treatment produced their own monoclonal antibodies and survived infection with the life-threatening pathogen Pseudomonas aeruginosa.

A memory B cell response to Zika virus in dengue-infected patients produced antibodies that were poorly neutralizing in vitro and instead enhanced infection.

A new method stimulates B cells to make human antigen-specific antibodies, obviating the need for vaccinating blood donors or hunting for rare B cells.

The mosquitoes that carry Zika may be able to transmit two other viruses at the same time.

The antibodies bind conserved viral parts, allowing them to neutralize all five Ebola types.

An experimental technique removes T cells that aid in vitro tumor growth.